#fhx23 Pitch 8 @glycanostics bietet Früherkennung und nicht-invasive patentierte Krebsdiagnostik zunächst bei Prostata- und Brustkrebs (80% Rate zb nutzbar für Screenings), später Pankreas und weitere Krebsarten
@glycanostics changes the way cancer is diagnosed. Giasay liquid biopsy is affordable, rapid, highly accurate, accessible and non-invasive immuno-assay.
New paper we collaborated on about the detection of a potential prostate cancer biomarker using nanostructured interfaces in @MDPIOpenAccess Functional Biomaterials.
Do you know that total #psa test, incorrectly but still massively used to screen for #prostatecancer, has a false positive rate of about 70% and false negative rate up to 20%?
Our solution to overcome this problem is our diagnostic test we´re launching this month commercially.
The EIC Corporate Day with @FreseniusKabi & @Medtronic is in full swing ⛳️
20 #EUeic innovators are pitching in Frankfurt 🇩🇪 on a wide array of topics, including:
🧬Cell and gene therapies
🧬Advanced/enhanced wound healing
Stay tuned for more 👀
Best ideas are born with a small help of a cup of coffee ☕. Let´s meet and talk at the #STARTUPWORLDCUP in San Francisco. Let´s make a change for the better tommorrow with our innovation for early cancer diagnostics. #SWC2022
We can’t wait to share great news about early-stage, highly accurate and unique cancer diagnostic test at the #STARTUPWORLDCUP. We strongly believe #SWC2023 will be a major milestone on our path to bringing this breakthrough innovation to patients world-wide!
We are enthusiastic about the new opportunities waiting for us at the #STARTUPWORLDCUP event in San Francisco. Innovations and innovators from all around the world will be competing and discussing their ideas at the #SWC2022.
It is my pleasure to announce that Glycanostics, Ltd. is one of the winners of the Enrich in the USA funding summit. We are looking forward to our virtual and later hopefully physical landing in the US market to bring our revolutionary product in cancer d…lnkd.in/eheSXXXX